REGENEREX PHARMA, INC. Gross Profit

Quick Answer

REGENEREX PHARMA, INC. reported Gross Profit of -$244.9 thousand for the year ending 2021.

  • REGENEREX PHARMA, INC. showed a decrease of -27,434.5% in Gross Profit from 2020 to 2021.
  • This data is from REGENEREX PHARMA, INC.'s annual report (Form 10-K), filed with the SEC on June 23, 2021.
  • XBRL data for this metric is available from 2020 to 2021 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q4 2019: $1.5 thousand | Q2 2020: $69.00 | Q3 2020: $86.00 | Q4 2020: -$183.00.
  • Historical annual values: Fiscal year 2021: -$244.9 thousand | Fiscal year 2020: $896.00.
  • Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: